https://www.selleckchem.com/pr....oducts/alflutinib-as
8%. Sixty-three intraoperative examinations were necessary to prevent a second operation on a patient. We recommend changing the clinical management of the axilla, resulting in fewer ALNDs in selected cN0, SLN-positive patients. In keeping with recent large clinical trial (ACOSOG Z0011, AMAROS and OTOASOR) data, our results support that intraoperative exam in selected cN0, SLN-positive Belgian patients is no longer effective.Colorectal carcinoma (CRC) is one of the most lethal malignancies, it ranks third in cancer-r
Like
Comment
Share
